Ocrevus Predicted to Be a Billion-dollar Blockbuster

From: Multiple Sclerosis News Today
By: Ed Tobias

The research firm Spherix Global Insights, which analyzes trends in the pharmaceutical industry, predicts that Ocrevus is “poised to blow past the $1B mark in the coming year. …” (read more).